FDA NDC Directory · JSON-LD · Markdown
NDC 83703-088 · VACCINE · INJECTION, SUSPENSION
| Generic name | INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE |
|---|---|
| Labeler / Manufacturer | Bamboo US BidCo LLC |
| Marketing category | Biologic License Application · App BLA125408 |
| Dosage form / route | INJECTION, SUSPENSION · INTRAMUSCULAR |
| Active ingredients | INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) (15 ug/.5mL) INFLUENZA A VIRUS A/VICTORIA/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) (15 ug/.5mL) INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) (15 ug/.5mL) |
| Marketing started | 20260801 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).